🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Last week, the OncoSil team was proud to participate in two key events in Turkey: 📍 17th European Digestive Surgery Postgraduate Course at Acibadem University – A big thank you to Prof. Dr. Guralp Ceyhan and the entire organizing committee for a well-curated program and warm

Milestone Moment in Italy! We are proud to announce the first OncoSil case at AORN Antonio Cardarelli Napoli, one of the largest and most respected hospitals in Italy. This makes AORN Cardarelli the 5th hospital in Italy to use OncoSil for the treatment of locally advanced

We’re Live on YouTube! 📺 We’re excited to announce the launch of the new OncoSil YouTube Channel – your new destination for the latest in targeted radiation therapy for pancreatic cancer. 👉 Subscribe now to explore: 🔹 Expert interviews 🔹 Clinical insights 🔹 Patient

OncoSil Medical (ASX: $OSL) is pleased to announce the Quarterly Report, with key deliverables over this period including: ✅ Record quarterly dose sales reported, on the back of continued growth in clinical adoption of the OncoSil™ device ✅ Advisory Board Meetings in UK and

OncoSil Medical (ASX: $OSL) is proud to announce that the Federal Joint Committee (G-BA) has officially initiated a tender to appoint a Contract Research Organisation (CRO) to conduct a clinical study involving the OncoSil™ device for the treatment of locally advanced pancreatic

🚨 Milestone Achievement in Italy! We’re proud to announce that, for the first time in Italy, two patients were implanted with our OncoSil device on the same morning at Forlì Hospital Morgagni-Pierantoni. This achievement reflects the exceptional collaboration and precision of

After a successful ESGE Days 2025 congress, we’re excited to share that OncoSil has been featured in the latest Treatment Strategies eBook! This recognition highlights the growing interest in our innovative approach to treating unresectable locally advanced pancreatic cancer and

📍 OncoSil at the London Pancreas Workshop | 2nd May 2025 We were proud to participate in the London Pancreas Workshop 2025, a key event bringing together leading experts in pancreatic disease to share insights, advances, and innovation. The workshop provided a valuable platform

🚨 BREAKTHROUGH DATA: OncoSil™ Outperforms SBRT in Pancreatic Cancer Treatment 🚨 We’re proud to share a major milestone for OncoSil Medical (ASX: $OSL) – results from the first-ever comparative analysis show that OncoSil™ significantly outperforms Stereotactic Body Radiation

📰 OncoSil featured in La Repubblica! We’re proud to share that the OncoSil™ treatment for patients with locally advanced pancreatic cancer, performed at AORN Cardarelli, has been featured in leading Italian newspaper La Repubblica. This marks a significant milestone in

📍 We’re all set and ready in Glasgow! OncoSil team is live at the BNMS Annual Spring Meeting 2025 – come and visit us at the OncoSil booth to learn more about our innovative treatment for locally advanced pancreatic cancer. We’re excited to connect with the nuclear medicine

OncoSil Medical (ASX: $OSL) has received firm commitments for an $8.7m capital raise supported by existing and new shareholders, including strong support from several Australian institutional investors. Key highlights include: ✅ Existing substantial shareholder, Pengana High

We were proud to participate in the SEMNIM 2025 Congress (Sociedad Española de Medicina Nuclear e Imagen Molecular) held in Valladolid from 21–23 May. A fantastic opportunity to connect with leading experts in nuclear medicine and molecular imaging, share insights, and explore

It’s been a busy and rewarding week for OncoSil Medical in Turkey! Last week we supported two OncoSil™ treatments at Bilkent City Hospital in Ankara, a fantastic milestone in our mission to bring innovative options to patients with locally advanced pancreatic cancer. We also

It's been another busy and rewarding week in Italy for the OncoSil team! We’re proud to share that five OncoSil™ treatments were successfully completed across four leading hospitals: 🏥 AORN Cardarelli – Naples 🏥 AOUI Verona – Verona 🏥 INT – Milan 🏥 AO San Camillo-Forlanini

We’re excited to share that the abstract on the OncoSil experience from Spanish centers has been selected for online publication at ASCO 2025! A huge thank you to Dr. Carmen Guillén-Ponce and all the dedicated Spanish sites involved in this important work. Your commitment to